Rivermark Medical, Inc. — Form D
Rivermark Medical, Inc. of MILWAUKEE, WI, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-31. The offering totals $4.0M, of which $2.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-07-31
- Form: D
- Accession: 0001893745-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.1M
- Remaining: $1.9M
- Investors: 3
- Date of first sale: 2023-07-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-488374
Issuer
- Name: Rivermark Medical, Inc.
- CIK: 0001893745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 758 N Broadway, Suite 234, MILWAUKEE, WI, 53202
- Phone: 773-307-9665
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Christopher Kaster | Director | Milwaukee, WI |
| Carter Meyer | Director | South San Francisco, CA |
| Anand Doraiswamy | Director | Dallas, TX |
| Anand Doraiswamy | Executive Officer | Dallas, TX |
| Josh Baltzell | Director | Dallas, TX |
| Scott Button | Director | Madison, WI |
| Adam Kadlec | Director | Milwaukee, WI |
| Adam Kadlec | Executive Officer | Milwaukee, WI |
| Matthew Ercolani | Director | Milwaukee, WI |
| Joseph Biller | Director | Milwaukee, WI |
Other filings by this issuer (3)
More